{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ganesananthan S"],"funding":["Medical Research Council"],"pagination":["H32-H42"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9650463"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["24(Suppl H)"],"pubmed_abstract":["Smart devices are a fundamental media for acquisition, processing, storage, and transfer of digital health data. The global penetration and high frequency usage of smart devices such as smartphones and fitness monitors provide us an opportunity for incorporation into clinical trials to generate more clinically meaningful data. Reporting of angina can significantly vary between patients and also within patients at different timepoints. Furthermore, the nature of angina can lead to variation in ways patients adapt their activities of daily living and hence reporting of symptoms and quality of life. Current clinical trials investigating the effects of intervention on angina do not accurately incorporate these patient centred outcomes and considerations. Hence, methods to contemporaneously ass"],"journal":["European heart journal supplements : journal of the European Society of Cardiology"],"pubmed_title":["Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR."],"pmcid":["PMC9650463"],"funding_grant_id":["MR/S021108/1"],"pubmed_authors":["Al-Lamee R","Ganesananthan S","Rajkumar CA","Francis D","Foley M"],"additional_accession":[]},"is_claimable":false,"name":"Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR.","description":"Smart devices are a fundamental media for acquisition, processing, storage, and transfer of digital health data. The global penetration and high frequency usage of smart devices such as smartphones and fitness monitors provide us an opportunity for incorporation into clinical trials to generate more clinically meaningful data. Reporting of angina can significantly vary between patients and also within patients at different timepoints. Furthermore, the nature of angina can lead to variation in ways patients adapt their activities of daily living and hence reporting of symptoms and quality of life. Current clinical trials investigating the effects of intervention on angina do not accurately incorporate these patient centred outcomes and considerations. Hence, methods to contemporaneously ass","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-04T23:36:24.702Z","creation":"2024-10-19T05:12:03.552Z"},"accession":"S-EPMC9650463","cross_references":{"pubmed":["36382002"],"doi":["10.1093/eurheartjsupp/suac058"]}}